.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
every single pronouncement, on any subject, issued via the medical cartel�s ministry of truth would fall on disbelieving ears, and only increase general outrage. .